Transparency Reporting

The purpose of this section is to disclose information required under the Medicines Australia Code of Conduct ( with respect to the interactions between the Australian affiliate of Gilead Sciences and Australian based HCPs.

From 30 August 2019, this information will now be held in a database, administered by Medicines Australia. This database is designed to be searchable as well as downloaded as a CSV file.

For further information about the details in the report, or to search the database, please visit